EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia

James P Holt-Martyn iD, Nicole Machado iD, James T T Coates, Rathi Puliyadi, Thomas Ashton, Elysia Traynor, Samina Aslam, Thomas K Wise, Gonzalo Rodriguez-Berriguete iD, Christopher J Schofield iD, Geoff S Higgins iD

RSC Medicinal Chemistry · 2026 · 17 (6) · 2925-2935

DOI: 10.1039/d5md00742a ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von James P Holt-Martyn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Research Laboratory, Department of Chemistry and the Ineos Institute for Antimicrobial Research, University of Oxford Oxford OX1 3TA UK chr…. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia, or low levels of oxygen, is a common feature of solid tumours that makes them resistant to cancer therapies. Electron transport chain inhibitors are a promising strategy for O 2 redistribution to target tumour hypoxia during radiotherapy.

Autor:innen und Institutionen

  • Chemistry Research Laboratory, Department of Chemistry and the Ineos Institute for Antimicrobial Research, University of Oxford Oxford OX1 3TA UK christopher.schofield@chem.ox.ac.uk.
  • Department of Oncology, University of Oxford Oxford OX3 7DQ UK gonzalo.rodriguez@oncology.ox.ac.uk geoffrey.higgins@oncology.ox.ac.uk.

ORCID-Profile: James P Holt-Martyn, Nicole Machado, Gonzalo Rodriguez-Berriguete, Christopher J Schofield, Geoff S Higgins

Förderung

  • HORIZON EUROPE Marie Sklodowska-Curie Actions

Zitieren

APA

Holt-Martyn, J. P., Machado, N., Coates, J. T. T., Puliyadi, R., Ashton, T., Traynor, E., Aslam, S., Wise, T. K., Rodriguez-Berriguete, G., Schofield, C. J., & Higgins, G. S. (2026). Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia. RSC Medicinal Chemistry, 17(6), 2925-2935. https://doi.org/10.1039/d5md00742a

Vancouver

Holt-Martyn JP, Machado N, Coates JTT, Puliyadi R, Ashton T, Traynor E, et al. Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia. RSC Medicinal Chemistry. 2026;17(6):2925-2935. doi:10.1039/d5md00742a

BibTeX
@article{HoltMartyn2026,
  author = {Holt-Martyn, James P and Machado, Nicole and Coates, James T T and Puliyadi, Rathi and Ashton, Thomas and Traynor, Elysia and Aslam, Samina and Wise, Thomas K and Rodriguez-Berriguete, Gonzalo and Schofield, Christopher J and Higgins, Geoff S},
  title = {Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {2925--2935},
  doi = {10.1039/d5md00742a}
}
Kostenlos starten →